Naloxone Hydrochloride Spray
Product Images NDC 50090-6710

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Naloxone Hydrochloride (NDC 50090-6710). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1 (a) (2y2 Figure 1 (a))

Figure 1 (a) (2y2 Figure 1 (a))
Naloxone is a medication that is used to reverse the effects of opioid overdose. This document provides information on the plasma concentration of naloxone at different doses and routes of administration. It indicates that naloxone can be administered through nasal spray, with varying concentrations and quantities depending on the situation. Additionally, it mentions the option of intramuscular injection. The table shows the hours postdose for further evaluation of naloxone's effects.*
FDA Label Image

Figure 1 (b) (2y2 Figure 1 (b))

Figure 1 (b) (2y2 Figure 1 (b))
The text describes different dosage options and corresponding plasma concentrations of Naloxone, a medication used to reverse opioid overdose. The dosage options include 2 mg or 4 mg administered as a spray in the nostrils, with different concentrations of the medication solution. The text also mentions an alternative method of administration, which is a 0.4 mg intramuscular injection. The time points mentioned in the text may be related to the post-dose observation period.*
FDA Label Image

Step 3 (2y2 Step 3)

Step 3 (2y2 Step 3)
FDA Label Image

Step 4 (2y2 Step 4)

Step 4 (2y2 Step 4)
FDA Label Image

Step 5 (2y2 Step 5)

Step 5 (2y2 Step 5)
FDA Label Image

Step 7 (2y2 Step 7)

Step 7 (2y2 Step 7)
This text appears to describe the actions of a person's hands, knees, and body positioning. It suggests that the hands provide support for the head, while the knees prevent the body from rolling onto the stomach.*
FDA Label Image

Label (Quick Start Image)

Label (Quick Start Image)
The text describes a nasal spray medication called Naloxone HCI. It is intended for use in the nose only and requires a prescription (RxOnly). Each dose contains 4 mg of naloxone HCI, which is equivalent to 36 mg of naloxone, in a 0.1 mL nasal spray. The medication should be stored below 77°F (25°C) and should not be exposed to temperatures exceeding 104°F (40°C). It should also be protected from light. The spray is intended for use in cases of known or suspected overdose in adults. The text also includes a warning not to test the device before use.*
FDA Label Image

Chemical Structure (Chemical Structure)

Chemical Structure (Chemical Structure)
FDA Label Image

Step 2 (Image 01)

Step 2 (Image 01)
FDA Label Image

Label Image (Lbl500906710)

Label Image (Lbl500906710)
FDA Label Image

Step 1 (Quick Start Guide Step 1)

Step 1 (Quick Start Guide Step 1)
FDA Label Image

Step 2 Image 2 (Quick Start Guide Step 2 Image 2)

Step 2 Image 2 (Quick Start Guide Step 2 Image 2)
FDA Label Image

Step 3 (Quick Start Guide Step 3)

Step 3 (Quick Start Guide Step 3)
This is not-readable.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.